Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-02

Clinical Trial Update: An Evaluation of Dupilumab in Patients With Nasal Polyposis And Chronic Symptoms Of Sinusitis [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating dupilumab for nasal polyposis with chronic sinusitis symptoms; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dupilumab (dupilumab)

Snippet

Sponsor: Sanofi | Conditions: Nasal Polyps | Phase 2 | Status: COMPLETED | Results posted: 2017-06-02